Thursday, December 3, 2020 Daily Archives

Innovations in the Manufacturing of Cell and Gene Therapies

by , and

Advancements in next-generation cell and gene therapies are fulfilling the promise of personalized medicine and attempting to cure and heal patients. Multiple approved products have been launched in global markets and the number of clinical trials continues to grow. Developing innovative advanced therapies is one of the biopharmaceutical industry’s greatest opportunities to dramatically improve patients’ lives. WuXi Advanced Therapies is a contract testing, development, and manufacturing organization (CTDMO) that has launched several innovative world-class platforms. It offers integrated platforms to…

December 3, 2020

Moderna working 24/7 on COVID-19 vaccine manufacture and supply

by

Moderna is confident its supply and distribution chains are robust enough to support COVID-19 vaccine scale up and roll out. The vaccine – mRNA-1273 – consists of mRNA coding for the SARS-CoV-2 spike protein inside a lipid nanoparticle. It is seen, along with jabs being developed Pfizer and AstraZeneca, as one of the best hopes for combatting the pandemic. So when clinical trial data released in November showed mRNA-1273 was 94.1% effective at protecting people from SARS-CoV-2, the news was…

December 3, 2020

KBI adds $150m commercial facility alongside pharma partner

by

KBI Biopharma will establish a commercial manufacturing facility in North Carolina with a co-investor, due to be operational Q1 2022. The contract development and manufacturing organization (CDMO) is developing the facility alongside an unnamed pharmaceutical partner to support the manufacture of the latter’s therapeutic protein programs. KBI will provide current good manufacturing practice (cGMP) biologics manufacturing for the partner, with a spokesperson for KBI Biopharma confirming that this would represent a “significant amount of [total] capacity.†However, the site will…

December 3, 2020